Request Demo

Last update 03 Oct 2026

Fujian Akeylink Biotechnology Co., Ltd

Subsidiary Company|2021|Fujian Sheng, China

Subsidiary Company|2021|Fujian Sheng, China

Last update 03 Oct 2026

Translational Medicine

Grant & Funding(NIH)

Overview

Basic Info

Introduction

Fujian Akeylink Biotechnology Co., Ltd. operates as a subsidiary under the majority ownership of Fujian Guangshengtang Pharmaceutical Co., Ltd. The company's primary focus lies in the development and marketing of the oral small molecule 3CL protease inhibitor Taierteve GST-HG171 tablets, aimed at combating COVID-19.

Tags

Infectious Diseases

Respiratory Diseases

Digestive System Disorders

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Infectious Diseases	4

Top 5 Drug Type	Count

Small molecule drug	5

Top 5 Target	Count

HIV-1 protease x SARS-CoV-2 3CLpro	1
HBV core protein x cccDNA	1
SARS-CoV-2 3CLpro(SARS-CoV-2-3C-like-proteinase)	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 04 Oct 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

1

1

Preclinical

Phase 3

2

1

Approved

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Atilotrelvir/Ritonavir ( HIV-1 protease x SARS-CoV-2 3CLpro )	COVID-19 More	Approved
Neracorvir ( HBV core protein x cccDNA )	Hepatitis B, Chronic More	Phase 3
Atilotrelvir ( SARS-CoV-2 3CLpro )	COVID-19 More	Phase 2/3
GST-HG181	COVID-19 More	Preclinical

Login to view more data

Deal

Boost your decision using our deal data.

login

or

view full example data

Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.

login

or

view full example data

Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.

login

or

view full example data

Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

login

or

view full example data

Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.

login

or

view full example data

Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.

login

or

view full example data

Unearth financing trends to validate and advance investment opportunities.

Hiro LS Researcher

The AI Search Engine Built to Accelerate Biopharma Decisions

Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.

Ask any biopharma research question→

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Discover Synapse Data Servers

Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!

Bio Sequences Search & Analysis

Sign up for free

Chemical Structures Search & Analysis

Sign up for free